BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3127112)

  • 1. Serum lipids in Norplant implants users: a cross-sectional study.
    Affandi B; Suherman SK; Djajalelana ; Prihartono DJ; Lubis F; Samil RS
    Contraception; 1987 Oct; 36(4):429-34. PubMed ID: 3127112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipid profile in women using levonorgestrel contraceptive implant, Norplant-2.
    Dash DS; Das S; Nanda U; Tripathy BB; Samal KC
    Contraception; 1988 Apr; 37(4):371-82. PubMed ID: 3133159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Norplant contraceptive subdermal implants on serum lipids and lipoproteins.
    Otubu JA; Towobola OA; Aisien AO; Ogunkeye OO
    Contraception; 1993 Feb; 47(2):149-59. PubMed ID: 8449015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Norplant implants on liver, lipid and carbohydrate metabolism.
    Singh K; Viegas OA; Loke DF; Ratnam SS
    Contraception; 1992 Feb; 45(2):141-53. PubMed ID: 1559336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study on the effects of Norplant implantable contraceptive on lipid, lipoprotein, and apolipoprotein metabolism in Singaporean women.
    Singh K; Ratnam SS
    Contraception; 1997 Aug; 56(2):77-83. PubMed ID: 9315415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical chemistry in women treated with levonorgestrel implants (Norplant) or a TCu 200 IUD.
    Croxatto HB; Diaz S; Robertson DN; Pavez M
    Contraception; 1983 Mar; 27(3):281-8. PubMed ID: 6406139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of subdermal levonorgestrel contraceptive implants, Norplant, on serum lipids.
    Shaaban MM; Elwan SI; Abdalla SA; Darwish HA
    Contraception; 1984 Nov; 30(5):413-9. PubMed ID: 6440737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
    Loke DF; Ng CS; Samsioe G; Holck S; Ratnam SS
    Contraception; 1990 Nov; 42(5):535-54. PubMed ID: 2125546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy after removal of Norplant implants contraceptive.
    Affandi B; Santoso SS; Djajadilaga ; Hadisaputra W; Moeloek FA; Prihartono J; Lubis F; Samil RS
    Contraception; 1987 Aug; 36(2):203-9. PubMed ID: 3123134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of Norplant on clinical chemistry in Singaporean acceptors after 1 year of use: metabolic changes.
    Viegas OA; Singh K; Liew D; Singh P; Ratnam SS
    Contraception; 1988 Jul; 38(1):79-89. PubMed ID: 3139359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Norplant-2 rods on clinical chemistry in Singaporean acceptors after 1 year of use: metabolic changes.
    Singh K; Viegas OA; Liew D; Singh P; Ratnam SS
    Contraception; 1988 Oct; 38(4):453-63. PubMed ID: 3145170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Buret J; Gillain D; Romus MA; Lambotte R
    Contraception; 1985 Apr; 31(4):395-408. PubMed ID: 3159546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S; Chen JK; Yang PJ; He ML; Li LM; Fan BC; Rekers H; Fotherby K
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year follow-up of changes in clinical chemistry in Singaporean Norplant-2 rod acceptors: metabolic changes.
    Singh K; Viegas OA; Liew D; Singh P; Ratnam SS
    Contraception; 1989 Feb; 39(2):147-54. PubMed ID: 2495889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant).
    Marsh MM; Butt AR; Riley SC; Rogers PA; Susil B; Affandi B; Findlay JK; Salamonsen LA
    Hum Reprod; 1995 Oct; 10(10):2584-9. PubMed ID: 8567775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids--a randomized comparative study.
    Biswas A; Viegas OA; Roy AC
    Contraception; 2003 Sep; 68(3):189-93. PubMed ID: 14561539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid and biochemical changes after low-dose oral contraception.
    Loke DF; Ng CS; Holck S; Hall PE; Ratnam SS
    Contraception; 1992 Sep; 46(3):227-41. PubMed ID: 1451519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced endothelial cell migratory signal production by endometrial explants from women using Norplant contraception.
    Subakir SB; Hadisaputra W; Siregar B; Irawati D; Santoso DI; Cornain S; Affandi B
    Hum Reprod; 1995 Oct; 10(10):2579-83. PubMed ID: 8567774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.